Astringency reducing agent
US-12453362-B2 · Oct 28, 2025 · US
US12186356B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12186356-B2 |
| Application number | US-201917258253-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 10, 2019 |
| Priority date | Jul 10, 2018 |
| Publication date | Jan 7, 2025 |
| Grant date | Jan 7, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a composition for preventing, alleviating, or treating allergic skin diseases comprising, as an active ingredient, an extract of gardenia fruit from which pigment is removed, and since the extract of gardenia fruit from which pigment is removed is more effective for allergic skin diseases compared to an extract of gardenia fruit from which pigment is not removed, the composition can be very advantageously used for allergic skin diseases, in particular, atopic dermatitis.
Opening claim text (preview).
What is claimed is: 1. A method for treating an allergic disease, the method comprising administering to a subject in need thereof a composition comprising, as an active ingredient, an extract of gardenia fruit from which pigment is removed, wherein the pigment is crocin. 2. The method of claim 1 , wherein the allergic disease is selected from the group consisting of atopic dermatitis, allergic dermatitis, contact dermatitis, skin hives, itch, insect allergy, food allergy, drug allergy, edema, anaphylaxis, allergic rhinitis, asthma, allergic conjunctivitis, and a combination thereof. 3. The method of claim 1 , wherein the extract of gardenia fruit from which pigment is removed is produced by: carrying out first extraction by adding an extraction solvent to gardenia fruit followed by filtration to obtain a first filtrate; adding an extraction solvent to residues remained after obtaining the first filtrate to obtain a second filtrate; mixing the first filtrate with the second filtrate; adding activated carbon for allowing pigment of gardenia fruit extract to get adsorbed onto the activated carbon; removing the activated carbon; and obtaining the extract of gardenia fruit from which the pigment is removed by filtration, concentration, and drying. 4. The method of claim 1 , wherein the composition is a pharmaceutical composition. 5. The method of claim 1 , wherein the composition is included in a quasi-pharmaceutical product. 6. The method of claim 5 , wherein the quasi-pharmaceutical product is a skin preparation for external use. 7. The method of claim 1 , wherein the composition is a functional health food composition.
Pre-filtration · CPC title
Applications, solvents · CPC title
Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization · CPC title
Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying · CPC title
Complex extraction schemes, e.g. fractionation or repeated extraction steps · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.